Adient (NYSE:ADNT – Get Free Report) had its price target dropped by equities researchers at Barclays from $27.00 to $24.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price target would indicate a potential upside of 22.29% from the stock’s current price.
ADNT has been the topic of a number of other research reports. Stifel Nicolaus cut their target price on shares of Adient from $29.00 to $24.00 and set a “buy” rating on the stock in a research report on Thursday. Cfra Research raised Adient from a “moderate sell” rating to a “hold” rating in a report on Thursday, August 7th. Bank of America boosted their price objective on Adient from $17.50 to $20.00 and gave the stock an “underperform” rating in a research report on Wednesday, September 10th. UBS Group dropped their target price on Adient from $28.00 to $22.00 and set a “neutral” rating for the company in a research report on Thursday. Finally, Zacks Research lowered Adient from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 18th. Two analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, Adient has a consensus rating of “Reduce” and an average price target of $21.63.
Get Our Latest Analysis on Adient
Adient Stock Performance
Adient (NYSE:ADNT – Get Free Report) last posted its quarterly earnings results on Wednesday, May 31st. The company reported ($0.13) earnings per share for the quarter. The company had revenue of $3.51 billion during the quarter. Adient had a negative net margin of 1.93% and a positive return on equity of 7.81%. As a group, analysts expect that Adient will post 1.76 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Adient
Institutional investors and hedge funds have recently made changes to their positions in the stock. Brooklyn Investment Group lifted its stake in shares of Adient by 23,600.0% in the first quarter. Brooklyn Investment Group now owns 2,133 shares of the company’s stock worth $27,000 after acquiring an additional 2,124 shares during the period. Hantz Financial Services Inc. increased its position in Adient by 62.6% during the 3rd quarter. Hantz Financial Services Inc. now owns 1,140 shares of the company’s stock valued at $27,000 after purchasing an additional 439 shares during the period. GAMMA Investing LLC raised its holdings in Adient by 157.5% during the 1st quarter. GAMMA Investing LLC now owns 2,235 shares of the company’s stock worth $29,000 after purchasing an additional 1,367 shares during the last quarter. MassMutual Private Wealth & Trust FSB lifted its position in shares of Adient by 991.0% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 2,182 shares of the company’s stock worth $42,000 after purchasing an additional 1,982 shares during the period. Finally, Fifth Third Bancorp lifted its position in shares of Adient by 544.4% in the 2nd quarter. Fifth Third Bancorp now owns 2,133 shares of the company’s stock worth $42,000 after purchasing an additional 1,802 shares during the period. Institutional investors and hedge funds own 92.44% of the company’s stock.
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Stories
- Five stocks we like better than Adient
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- The Role Economic Reports Play in a Successful Investment Strategy
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- A Deeper Look at Bid-Ask Spreads
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.
